Women’s Health Update: From Ground-Breaking Antidepressant Results to Policy Changes Impacting Millions of Women and Children
This week’s Women’s Health Update brings you the biggest developments across oncology, infectious disease, neurology, reproductive health, and more.
🔬 Key highlights:
• FDA halts Gilead’s weekly HIV pill trials over immune cell safety concerns
• Gilgamesh’s new MDD drug achieves 94% remission in just 29 days
• CDC drops routine COVID vaccine recs for healthy kids and pregnant women
• Oral UTI antibiotic from Spero & GSK clears Phase 3 early for efficacy
• Roche’s fenebrutinib halts MS progression for nearly 2 years
• ENHERTU combo cuts disease progression risk by 44% in HER2+ breast cancer
• KEYTRUDA + Trodelvy outperform chemo in triple-negative breast cancer
• China launches first homegrown 9-valent HPV vaccine
• NHS updates cervical screening with personalized intervals
• U.S. aid cuts leave millions in contraceptives stranded
This video is packed with essential information for healthcare professionals, researchers, and anyone passionate about progress in women’s health.
📢 Stay Ahead in Women’s Health Research!
✅ Like, share, and subscribe for weekly updates on Women’s Health and specific diseases like breast cancer and endometriosis!
#WomensHealth #ClinicalTrials #BreastCancer #ReproductiveHealth #Neurology #HIVResearch #PublicHealth #HealthcareNews #LucidQuest #MedicalInnovation